Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.109 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.4.2.2 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.4.2.3 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.4.8 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.617.1 (Kappa)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.4.3 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.46.5 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.4.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
P.1.16 (Gamma)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.10.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.4.5 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.34.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.4.2.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.16NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.9.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.55NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.39NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.64NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.8 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.7 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.41NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.90 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.23NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.30NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.1.12NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.87NWon-NGTTGCGACTACGTGATGAGG20552884928830R-17354.8South Korea
BA.5.2.33NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.46NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.58 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.26NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.15NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.21NWon-NGTTGCGACTACGTGATGAGG20552884928830R-21584South Korea
BA.2.31NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CP.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBGNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.98 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.32NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.1.13NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EF.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XPNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DN.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BE.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.1.15NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.7.16NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.3.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CQ.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-21584South Korea
EC.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.52NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.3.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CH.1.1.7NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used